Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 3/2011

01-09-2011 | Case Report

Cardiac Metastasis: A Rare Involvement of Primitive Neuroectodermal Tumour of the Lung

Authors: Harris A. Ngow, Wan Mohd Nowalid Wan Khairina

Published in: Pathology & Oncology Research | Issue 3/2011

Login to get access

Abstract

A 15 year-old adolescent was referred with 2 month history of worsening of breathlessness and haemoptysis. He also reported constitutional symptoms of fever, poor appetite and weight loss. The chest roentgenogram showed a massive right pleural effusion with apparent cardiomegaly. The cardiac silhouette over the right heart border was obliterated and the mediastinum was widened. Computed tomogram of the thorax showed a bulky heterogeneous mass in the right lung with extension to the heart. Subsequent CT guided lung biopsy revealed Primitive Neuroectodermal tumour (PNET). Here, we illustrate the clinical course of an aggressive pulmonary PNET with lethal cardiac metastasis.
Literature
1.
Besirli K, Arslan C, Tuzun H, Oz B (2000) The primitive Neuroectodermal tumour of the heart. Eur J Cardiothorac Surg 18:619–621PubMedCrossRef
2.
Charney DA, Charney JM, Ghali VS, Teplitz C (1996) Primitive Neuroectodermal tumour of the myocardium: a case report, review of the literature, immunohistochemical and ultrastructural study. Hum Pathol 27:1365–1369PubMedCrossRef
3.
Hendershot E (2005) Treatment approaches for metastatic Ewing’s sarcoma: a review of the literature. J Pediatr Oncol Nurs 22:339–352PubMedCrossRef
4.
Askin FB, Rosai J, Sibley RK, Dehner LP, McAlister WH (1979) Malignant small cell tumour of the thoracopulmonary region in childhood. Cancer 43:2438–2451PubMedCrossRef
5.
6.
Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J et al (2002) Peripheral blood stem cell support reduces the toxicity of intensive chemotharpy for children and adolescents with metastatic sarcomas. Cancer 95:1354–1365PubMedCrossRef
7.
Marley EF, Liapis H, Humphry PA, Nadler RB, Siegel CL, Zhu X, Brandt SM, Dehner LP (1997) Primitive Neuroectodermal tumor of the kidney another enigma: a pathologic, immunohistochemical and molecular diagnostic study. Am J Surg Pathol 21:354–359PubMedCrossRef
Metadata
Title
Cardiac Metastasis: A Rare Involvement of Primitive Neuroectodermal Tumour of the Lung
Authors
Harris A. Ngow
Wan Mohd Nowalid Wan Khairina
Publication date
01-09-2011
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2011
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-010-9328-9

Other articles of this Issue 3/2011

Pathology & Oncology Research 3/2011 Go to the issue

Research

N-myc Downstream-regulated Gene 1 (NDRG1) a Differentiation Marker of Human Breast Cancer

Research

Glucocorticoid Receptor Expression and Antiproliferative Effect of Dexamethasone on Human Melanoma Cells

Research

Relationship Between Hypermethylated MGMT Gene and Osteosarcoma Necrosis Rate After Chemotherapy

Research

Combined Inhibition of PI3K and mTOR Exerts Synergistic Antiproliferative Effect, but Diminishes Differentiative Properties of Rapamycin in Acute Myeloid Leukemia Cells

Research

Expression of p53, Ki-67 and c-Myc Proteins is Predictive of the Surgical Molecular Margin in Colorectal Carcinoma

Research

Divergent Squamous Differentiation in Upper Urothelial Carcinoma—Comparative Clinicopathological and Molecular Study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits